» Authors » Rita Ortolano

Rita Ortolano

Explore the profile of Rita Ortolano including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 30
Citations 195
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Capalbo D, Moracas C, Guazzarotti L, Baronio F, Stancampiano M, Ortolano R, et al.
J Clin Endocrinol Metab . 2025 Feb; PMID: 39919031
Context: There has been concern about a potential increase in the incidence or severity of Coronavirus Disease 2019 (COVID-19) in individuals with adrenal insufficiency (AI). Data on the course of...
2.
Candela E, Montanari G, Di Blasi E, Baronio F, Cassio A, Ortolano R
J Endocrinol Invest . 2025 Jan; PMID: 39821528
Purpose: Galactosemia is a rare inborn error of galactose metabolism. There are several forms, the most severe being classic galactosemia (CG), which begins in the first few days of life....
3.
Ortolano R, Cantarelli E, Baronio F, Assirelli V, Candela E, Mastrangelo C, et al.
Children (Basel) . 2024 Sep; 11(9). PMID: 39334669
: Levothyroxine (L-T4) is available for use in congenital hypothyroidism (CH) in three formulations: tablets, drops, and oral solution. This study aims to compare the efficacy and safety of all...
4.
Tseretopoulou X, Ali S, Bryce J, Amin N, Atapattu N, Bachega T, et al.
J Endocr Soc . 2024 Sep; 8(10):bvae145. PMID: 39258010
Background: It is unclear whether targeted monitoring of acute adrenal insufficiency (AI) related adverse events (AE) such as sick day episodes (SDEs) and hospitalization rate in congenital adrenal hyperplasia (CAH)...
5.
Baronio F, Assirelli V, Deiana G, AlQaisi R, Ortolano R, Di Natale V, et al.
Medicina (Kaunas) . 2024 Mar; 60(3). PMID: 38541222
: bLH is considered an excellent biochemical predictor of CPP. However, its utilization in clinical practice shows some uncertainties. This study aims to evaluate the diagnostic power of bLH and...
6.
Bruni L, Cassio A, Di Natale V, Baronio F, Ortolano R, Pession A, et al.
Children (Basel) . 2023 Sep; 10(9). PMID: 37761452
An infant with a prenatal diagnosis of citrullinemia, who started standard treatment at birth (L-arginine; sodium benzoate and a personalized diet characterized by a low protein intake and supplementation of...
7.
Ortolano R, Cassio A, Alqaisi R, Candela E, Di Natale V, Assirelli V, et al.
Children (Basel) . 2023 Sep; 10(9). PMID: 37761418
Testicular adrenal rest tumors (TARTs) are a common complication in male patients with congenital adrenal hyperplasia (CAH). The aim of our cross-sectional cohort study is to estimate the frequency of...
8.
Baronio F, Marzatico A, De Iasio R, Ortolano R, Fanolla A, Radetti G, et al.
J Clin Med . 2023 Mar; 12(6). PMID: 36983190
Premature pubarche (PP) could represent the first manifestation of non-classic congenital adrenal hyperplasia caused by 21 hydroxylase deficiency (NC21OHD) (10-30% of cases). In the last 20 years, the necessity of...
9.
Candela E, Zagariello M, Di Natale V, Ortolano R, Righetti F, Assirelli V, et al.
Children (Basel) . 2023 Feb; 10(2). PMID: 36832525
Cysthiatonine beta-synthase (CBS) deficiency (CBSD) is an autosomal recessive rare disorder caused by variations on that leads to impaired conversion of homocysteine (Hcy) to cystathionine. Marked hyperhomocysteinemia is the hallmark...
10.
Ruoppolo M, Malvagia S, Boenzi S, Carducci C, Dionisi-Vici C, Teofoli F, et al.
Int J Neonatal Screen . 2022 Aug; 8(3). PMID: 35997437
Newborn screening (NBS) for inborn errors of metabolism is one of the most advanced tools for secondary prevention in medicine, as it allows early diagnosis and prompt treatment initiation. The...